Novartis AG (NVS): Price and Financial Metrics

NVS POWR Grades

• Stability is the dimension where NVS ranks best; there it ranks ahead of 98.95% of US stocks.
• NVS's strongest trending metric is Stability; it's been moving up over the last 52 weeks.
• NVS ranks lowest in Momentum; there it ranks in the 18th percentile.

NVS Stock Summary

• NVS has a market capitalization of $189,384,694,263 -- more than approximately 98.84% of US stocks.
• With a one year PEG ratio of 117.61, Novartis Ag is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 79.83% of US stocks.
• In terms of volatility of its share price, NVS is more volatile than just 3.23% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to Novartis Ag, a group of peers worth examining would be SAP, ABBV, AZN, TXN, and NVO.
• NVS's SEC filings can be seen here. And to visit Novartis Ag's official web site, go to www.novartis.com.

NVS Valuation Summary

• In comparison to the median Healthcare stock, NVS's price/sales ratio is 5.26% higher, now standing at 4.
• NVS's price/sales ratio has moved down 0.7 over the prior 243 months.
• Over the past 243 months, NVS's EV/EBIT ratio has gone up 1.9.

Below are key valuation metrics over time for NVS.

NVS Growth Metrics

• Its 5 year price growth rate is now at 12.6%.
• Its 3 year net cashflow from operations growth rate is now at 20.75%.
• The year over year revenue growth rate now stands at -0.09%.

Over the past 49 months, NVS's revenue has gone up $2,330,000,000.

The table below shows NVS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	51,556	13,423	8,984
2021-03-31	49,884	13,252	7,955
2020-12-31	49,898	13,650	8,072
2020-09-30	49,584	13,185	7,103
2020-06-30	49,528	14,591	7,210
2020-03-31	49,930	13,741	12,142

NVS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NVS has a Quality Grade of B, ranking ahead of 84.28% of graded US stocks.
• NVS's asset turnover comes in at 0.406 -- ranking 115th of 681 Pharmaceutical Products stocks.
• GHSI, BMY, and PBH are the stocks whose asset turnover ratios are most correlated with NVS.

The table below shows NVS's key quality metrics over time.